INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 49m ago
HOUSE PTR9m ago
SEC 13F9m ago
ROBINHOOD CHAIN9m ago
Public company

BICYCLE THERAPEUTICS PLC

BCYCCIK 0001761612

EDGAR filingsOpen in network
Price$3.61
1 year-41.5%
Disclosed transactions45
Buys / sells0 / 38
Max Insider Score40
Connections with evidence8

BCYC · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
PS
Perry Jennifer ScottChief Operating Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale · 10b5-1 plan
SELL$3,796
1,094 sh
Oct 2, 2026

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Lobbied forevidence
    LMH STRATEGIC SOLUTIONSLDA Q2 2026 second quarter · Health issues, Pharmacy · Aug 26, 2026
  • ← Insider ofevidence
    Skynner MichaelCHIEF SCIENTIFIC OFFICER · Apr 6, 2026
  • ← Insider ofevidence
    Perry Jennifer ScottChief Operating Officer · Apr 6, 2026
  • ← Insider ofevidence
Oct 6, 2026
traded Oct 2, 2026
+4d
SEC FORM 4

Evidence

29
TA
Thompson Travis AlvinChief Financial Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$3,099
893 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC FORM 4

Evidence

32
LK
Lee KevinDirector, CHIEF EXECUTIVE OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$5,848
1,638 sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC FORM 4

Evidence

29
HF
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$864
242 sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC FORM 4

Evidence

32
SM
Skynner MichaelCHIEF SCIENTIFIC OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$6,739
1,942 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC FORM 4

Evidence

32
LK
Lee KevinDirector, CHIEF EXECUTIVE OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$21K
6,167 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC FORM 4

Evidence

32
SM
Skynner MichaelCHIEF SCIENTIFIC OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$1,796
503 sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC FORM 4

Evidence

29
TA
Thompson Travis AlvinChief Financial Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$282
79 sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC FORM 4

Evidence

29
HF
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$5,455
1,572 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC FORM 4

Evidence

40
SC
Swanton Robert CharlesDirector
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$12K
3,431 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC FORM 4

Evidence

13
PS
Perry Jennifer ScottChief Operating Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale · 10b5-1 plan
SELL$1,232
326 sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC FORM 4

Evidence

13
PS
Perry Jennifer ScottChief Operating Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale · 10b5-1 plan
SELL$285
80 sh
Oct 5, 2026Oct 6, 2026
traded Oct 5, 2026
+1dSEC FORM 4

Evidence

22
PS
Perry Jennifer ScottChief Operating Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale · 10b5-1 plan
SELL$4,424
1,036 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC FORM 4

Evidence

16
PS
Perry Jennifer ScottChief Operating Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale · 10b5-1 plan
SELL$185
43 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC FORM 4

Evidence

38
HF
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$6,431
1,506 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC FORM 4

Evidence

38
LK
Lee KevinDirector, CHIEF EXECUTIVE OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$25K
5,905 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC FORM 4

Evidence

32
LK
Lee KevinDirector, CHIEF EXECUTIVE OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$7,486
1,737 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC FORM 4

Evidence

38
SM
Skynner MichaelCHIEF SCIENTIFIC OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$7,938
1,859 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC FORM 4

Evidence

32
SM
Skynner MichaelCHIEF SCIENTIFIC OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$2,293
532 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC FORM 4

Evidence

32
TA
Thompson Travis AlvinChief Financial Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$448
104 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC FORM 4

Evidence

16
PS
Perry Jennifer ScottChief Operating Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale · 10b5-1 plan
SELL$1,445
333 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC FORM 4

Evidence

32
HF
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$1,099
255 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC FORM 4

Evidence

38
TA
Thompson Travis AlvinChief Financial Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$3,497
819 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC FORM 4

Evidence

36
SM
Skynner MichaelCHIEF SCIENTIFIC OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$9,226
1,879 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC FORM 4

Evidence

32
SM
Skynner MichaelCHIEF SCIENTIFIC OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$2,651
525 sh
Apr 6, 2026Apr 6, 2026
traded Apr 6, 2026
+0dSEC FORM 4

Evidence

32
HF
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$7,468
1,521 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC FORM 4

Evidence

16
PS
Perry Jennifer ScottChief Operating Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale · 10b5-1 plan
SELL$1,678
333 sh
Apr 6, 2026Apr 6, 2026
traded Apr 6, 2026
+0dSEC FORM 4

Evidence

36
LK
Lee KevinDirector, CHIEF EXECUTIVE OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$29K
5,967 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC FORM 4

Evidence

32
TA
Thompson Travis AlvinChief Financial Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$515
102 sh
Apr 6, 2026Apr 6, 2026
traded Apr 6, 2026
+0dSEC FORM 4

Evidence

32
TA
Thompson Travis AlvinChief Financial Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$3,923
799 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC FORM 4

Evidence

16
PS
Perry Jennifer ScottChief Operating Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale · 10b5-1 plan
SELL$187
37 sh
Apr 6, 2026Apr 6, 2026
traded Apr 6, 2026
+0dSEC FORM 4

Evidence

20
PS
Perry Jennifer ScottChief Operating Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale · 10b5-1 plan
SELL$5,097
1,038 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC FORM 4

Evidence

32
HF
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$1,268
251 sh
Apr 6, 2026Apr 6, 2026
traded Apr 6, 2026
+0dSEC FORM 4

Evidence

32
LK
Lee KevinDirector, CHIEF EXECUTIVE OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$8,666
1,716 sh
Apr 6, 2026Apr 6, 2026
traded Apr 6, 2026
+0dSEC FORM 4

Evidence

5
TA
Thompson Travis AlvinChief Financial Officer
BCYCBICYCLE THERAPEUTICS PLC
Grant or award
A—
58.0K sh
Feb 3, 2026Feb 4, 2026
traded Feb 3, 2026
+1dSEC FORM 4

Evidence

26
HF
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$19K
2,827 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC FORM 4

Evidence

21
HF
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
BCYCBICYCLE THERAPEUTICS PLC
Grant or award
A—
50.0K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC FORM 4

Evidence

22
TA
Thompson Travis AlvinCHIEF ACCOUNTING OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$7,192
1,115 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC FORM 4

Evidence

9
TA
Thompson Travis AlvinCHIEF ACCOUNTING OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Grant or award
A—
75.0K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC FORM 4

Evidence

9
HF
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
BCYCBICYCLE THERAPEUTICS PLC
Grant or award
A—
100.0K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC FORM 4

Evidence

22
HF
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$15K
2,367 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC FORM 4

Evidence

21
TA
Thompson Travis AlvinCHIEF ACCOUNTING OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Grant or award
A—
37.5K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC FORM 4

Evidence

17
SC
Swanton Robert CharlesDirector
BCYCBICYCLE THERAPEUTICS PLC
Grant or award
A—
3,726 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC FORM 4

Evidence

26
TA
Thompson Travis AlvinCHIEF ACCOUNTING OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$8,956
1,317 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC FORM 4

Evidence

9
SC
Swanton Robert CharlesDirector
BCYCBICYCLE THERAPEUTICS PLC
Grant or award
A—
7,453 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC FORM 4

Evidence

Lee Kevin
Director, CHIEF EXECUTIVE OFFICER · Apr 6, 2026
  • ← Insider ofevidence
    Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF · Jan 6, 2026
  • ← Insider ofevidence
    Swanton Robert CharlesDirector · Jan 6, 2026
  • ← Insider ofevidence
    Thompson Travis AlvinCHIEF ACCOUNTING OFFICER · Jan 6, 2026

    • Lobbying

    $300K reported · de-duplicated
    2026 Q2 $150K via firms2026 Q1 $150K via firms
    • LMH STRATEGIC SOLUTIONS—2026 Q1 · posted Aug 26, 2026 · Health issues, Pharmacy
    • LMH STRATEGIC SOLUTIONS$150K2026 Q1 · posted Aug 26, 2026 · Health issues, Pharmacy
    • LMH STRATEGIC SOLUTIONS$150K2026 Q2 · posted Aug 26, 2026 · Health issues, Pharmacy

    Connected PAC contributions

    FEC · direct to members

    No contributions from a PAC connected to this company.